ENZON PHARMACEUTICALS INC
ENZN
ENZN was delisted on the 19th of May, 2016.
67 hedge funds and large institutions have $23.4M invested in ENZON PHARMACEUTICALS INC in 2014 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 23 reducing their positions, and 19 closing their positions.
11% less funds holding
Funds holding: 75 → 67 (-8)
16% less capital invested
Capital invested by funds: $27.9M → $23.4M (-$4.45M)
37% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 19
43% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 23
78% less call options, than puts
Call options by funds: $4K | Put options by funds: $18K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Schroder Investment Management Group
London,
United Kingdom
|
+$323K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$288K |
| 3 |
Millennium Management
New York
|
+$194K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$174K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$154K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$1.31M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.1M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$821K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$579K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$312K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
RhumbLine Advisers
Boston,
Massachusetts
| – | -$57K | -54,945 | Closed |
|
|
PPA
77
Parametric Portfolio Associates
Seattle,
Washington
| – | -$49K | -48,008 | Closed |
|
78
ProShare Advisors
Bethesda,
Maryland
| – | -$39K | -38,013 | Closed |
|
|
AIG
79
American International Group
New York
| – | -$26.3K | -25,545 | Closed |
|
80
HighTower Advisors
Chicago,
Illinois
| – | -$18K | -17,883 | Closed |
|
81
Principal Financial Group
Des Moines,
Iowa
| – | -$17K | -16,038 | Closed |
|
82
Citigroup
New York
| – | -$11K | -10,073 | Closed |
|
ENZN Hedge Fund Activity: Q2 2014 in Review
67 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in ENZON PHARMACEUTICALS INC (ENZN) for Q2 2014, worth a combined $23.4M — down 16% from $27.9M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of ENZN and 12 opened new positions — a net loss of 7 holders — while 23 trimmed existing stakes and 13 added.
The largest buyer was Schroder Investment Management Group, adding an estimated $323K. The largest seller was State Street, cutting an estimated $1.31M.
- 67 institutional investors held ENZON PHARMACEUTICALS INC (ENZN) as of Q2 2014, down from 75 in Q1 2014.
- Funds reported $23.4M of ENZON PHARMACEUTICALS INC stock for Q2 2014, down 16% quarter-over-quarter.
- 12 funds opened new ENZON PHARMACEUTICALS INC positions in Q2 2014 and 19 closed out, a net change of -7 holders.
- The largest ENZON PHARMACEUTICALS INC buyer in Q2 2014 was Schroder Investment Management Group, an estimated $323K added.
- The largest ENZON PHARMACEUTICALS INC seller in Q2 2014 was State Street, an estimated $1.31M sold.
Based on aggregated 13F filings for Q2 2014.